Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged over 60 years old.
- People who have been diagnosed with Alzheimer's Disease according to a specific set of recognised diagnostic guidelines known as the NIA-AA criteria for probable Alzheimer's Disease.
- People whose dementia has been rated as mild or less, based on a standard assessment tool called the Clinical Dementia Rating scale (a global score of 1 or lower).
- People who are either not currently taking Alzheimer's medications (such as acetylcholinesterase inhibitors or memantine), or who have been on a steady, unchanged dose of these medications for at least six months.
- People who are fluent in English.
- People who have a caregiver who is also willing and able to take part in the study.
Who may not be able to join:
- People who have pre-existing structural problems in the brain, such as significant damage to the white matter, a brain tumour, a past stroke, or bleeding within the skull.
- People who have other neurological or psychiatric conditions, or other serious health problems, that would make surgery unsafe or unsuitable for them.
- People who are not fluent in English, as the trial involves standard cognitive tests and ongoing communication that are conducted in English.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Taufik A. Valiante, MD PhD FRCS, University Health Network, Toronto
Phone: 416-918-4059
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Intervention Feasibility - Recruitment Rates; Intervention Feasibility - Adherence to Study Protocol; Intervention Feasibility - Attrition Rates; Intervention Feasibility - Participant Evaluation of Intervention; Intervention Safety - Adverse Events (AEs) and Serious Adverse Events (SAEs); Intervention Safety - AE Severity; Intervention Safety - AE Relationship to Study Intervention; Intervention Safety - AE Outcome
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.